REPLIGEN CORP Depreciation
REPLIGEN CORP (RGEN) reported Depreciation of $39.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-26
- REPLIGEN CORP depreciation for the quarter ending 2022-12-31 was $7.10M, a 39.22% increase year-over-year.
- REPLIGEN CORP depreciation for the quarter ending 2022-09-30 was $6.10M, a 41.86% increase year-over-year.
- REPLIGEN CORP depreciation for the quarter ending 2022-06-30 was $5.50M, a 44.74% increase year-over-year.
- REPLIGEN CORP depreciation for the quarter ending 2022-03-31 was $5.20M, a 57.58% increase year-over-year.
- REPLIGEN CORP depreciation for fiscal 2025 was $39.70M, a 13.43% increase from fiscal 2024.
- REPLIGEN CORP depreciation for fiscal 2024 was $35.00M, a 5.41% decline from fiscal 2023.
- REPLIGEN CORP depreciation for fiscal 2023 was $37.00M, a 54.81% increase from fiscal 2022.
- REPLIGEN CORP depreciation for fiscal 2022 was $23.90M, a 45.73% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $39.70M 10-K · filed 2026-02-26 | |||||||
| 2024-12-31 | $35.00M 10-K · filed 2026-02-26 | |||||||
| 2023-12-31 | $37.00M 10-K · filed 2026-02-26 | |||||||
| 2022-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $13.20M derived: sum of 2 quarters · filed 2025-03-14 | $18.70M derived: sum of 3 quarters · filed 2025-03-14 | $23.90M 10-K · filed 2025-03-14 | ||||
| 2022-09-30 | $6.10M 10-Q · filed 2022-11-01 | $11.60M derived: sum of 2 quarters · filed 2022-11-01 | $16.80M 10-Q · filed 2022-11-01 | $21.90M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-06-30 | $5.50M 10-Q · filed 2022-08-02 | $10.70M 10-Q · filed 2022-08-02 | $15.80M derived: sum of 3 quarters · filed 2024-11-18 | $20.10M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-03-31 | $5.20M 10-Q · filed 2022-04-27 | $10.30M derived: sum of 2 quarters · filed 2024-11-18 | $14.60M derived: sum of 3 quarters · filed 2024-11-18 | $18.40M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2021-12-31 | $5.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $9.40M derived: sum of 2 quarters · filed 2024-11-18 | $13.20M derived: sum of 3 quarters · filed 2024-11-18 | $16.40M 10-K/A · filed 2024-11-18 | ||||
| 2021-09-30 | $4.30M 10-Q · filed 2022-11-01 | $8.10M derived: sum of 2 quarters · filed 2022-11-01 | $11.30M 10-Q · filed 2022-11-01 | $14.50M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $3.80M 10-Q · filed 2022-08-02 | $7.00M 10-Q · filed 2022-08-02 | $10.20M derived: sum of 3 quarters · filed 2023-02-22 | $13.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $3.30M 10-Q · filed 2022-04-27 | $6.40M derived: sum of 2 quarters · filed 2023-02-22 | $9.20M derived: sum of 3 quarters · filed 2023-02-22 | $11.80M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $5.90M derived: sum of 2 quarters · filed 2023-02-22 | $8.50M derived: sum of 3 quarters · filed 2023-02-22 | $10.90M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $2.80M 10-Q · filed 2021-10-28 | $5.40M derived: sum of 2 quarters · filed 2021-10-28 | $7.80M 10-Q · filed 2021-10-28 | $10.00M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $2.60M 10-Q · filed 2021-07-27 | $5.10M 10-Q · filed 2021-07-27 | $7.20M derived: sum of 3 quarters · filed 2022-02-17 | $9.00M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $2.50M 10-Q · filed 2021-05-04 | $4.60M derived: sum of 2 quarters · filed 2022-02-17 | $6.40M derived: sum of 3 quarters · filed 2022-02-17 | $8.20M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $3.90M derived: sum of 2 quarters · filed 2022-02-17 | $5.70M derived: sum of 3 quarters · filed 2022-02-17 | $7.30M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $1.80M 10-Q · filed 2020-11-05 | $3.60M derived: sum of 2 quarters · filed 2020-11-05 | $5.20M 10-Q · filed 2020-11-05 | $6.50M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $1.80M 10-Q · filed 2020-07-30 | $3.30M 10-Q · filed 2020-07-30 | $4.70M derived: sum of 3 quarters · filed 2021-02-24 | $6.00M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $1.60M 10-Q · filed 2020-05-06 | $2.90M derived: sum of 2 quarters · filed 2021-02-24 | $4.20M derived: sum of 3 quarters · filed 2021-02-24 | $5.50M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.60M derived: sum of 2 quarters · filed 2021-02-24 | $3.90M derived: sum of 3 quarters · filed 2021-02-24 | $5.20M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $1.30M 10-Q · filed 2019-10-31 | $2.60M derived: sum of 2 quarters · filed 2019-10-31 | $3.90M 10-Q · filed 2019-10-31 | $3.87M 10-Q · filed 2018-11-01 | $5.11M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | $1.30M 10-Q · filed 2019-08-01 | $2.60M 10-Q · filed 2019-08-01 | $2.60M 10-Q · filed 2018-08-02 | $3.81M derived: sum of 3 quarters · filed 2020-02-26 | $4.94M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | $1.30M 10-Q · filed 2019-05-09 | $1.28M 10-Q · filed 2018-05-08 | $2.51M derived: sum of 2 quarters · filed 2020-02-26 | $3.64M derived: sum of 3 quarters · filed 2020-02-26 | $4.57M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.34M derived: sum of 2 quarters · filed 2020-02-26 | $3.27M derived: sum of 3 quarters · filed 2020-02-26 | $4.20M 10-K · filed 2020-02-26 | $4.24M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $2.06M derived: sum of 2 quarters · filed 2018-11-01 | $2.99M 10-Q · filed 2018-11-01 | $3.93M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.86M 10-Q · filed 2018-08-02 | $2.80M derived: sum of 3 quarters · filed 2019-03-01 | $3.62M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $928.00K 10-Q · filed 2018-05-08 | $1.87M derived: sum of 2 quarters · filed 2019-03-01 | $2.69M derived: sum of 3 quarters · filed 2019-03-01 | $3.48M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.76M derived: sum of 2 quarters · filed 2019-03-01 | $2.55M derived: sum of 3 quarters · filed 2019-03-01 | $3.30M 10-K · filed 2019-03-01 | $3.27M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.61M derived: sum of 2 quarters · filed 2017-11-09 | $2.36M 10-Q · filed 2017-11-09 | $3.10M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.53M 10-Q · filed 2017-08-03 | $2.28M derived: sum of 3 quarters · filed 2018-02-22 | $3.04M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $751.00K 10-Q · filed 2017-05-04 | $1.50M derived: sum of 2 quarters · filed 2018-02-22 | $2.25M derived: sum of 3 quarters · filed 2018-02-22 | $3.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.50M derived: sum of 2 quarters · filed 2018-02-22 | $2.25M derived: sum of 3 quarters · filed 2018-02-22 | $3.00M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $757.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.50M derived: sum of 2 quarters · filed 2016-11-03 | $2.25M 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | $745.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.49M 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | $749.00K 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | $2.59M 10-K · filed 2017-02-23 | |||||||
| 2013-12-31 | $2.09M 10-K · filed 2016-02-25 | |||||||
| 2012-12-31 | $2.49M 10-K · filed 2015-03-17 | |||||||
| 2011-12-31 | $1.12M 10-K · filed 2014-03-14 | |||||||
| 2011-03-31 | $355.00K derived: 10-K 12 month − 10-K 9 month · filed 2013-03-15 | $1.50M 10-K · filed 2013-03-15 | ||||||
| 2010-12-31 | $1.14M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |